LifeSign
Private Company
Funding information not available
Overview
LifeSign is a long-established, privately-held diagnostics company headquartered in Skillman, New Jersey, with operational presence in Piscataway. It has a commercial-stage portfolio of rapid diagnostic tests (RDTs) focused on infectious disease, women's health, cardiac markers, and drugs of abuse. The company leverages a traditional lateral flow assay platform, manufacturing its tests under stringent regulatory standards for global distribution. Its business model is centered on the sale of physical diagnostic devices and consumables, positioning it in the competitive but stable point-of-care testing market.
Technology Platform
Lateral flow assay (LFA) technology for rapid point-of-care immunochromatographic tests. Products are developed and manufactured under ISO, FDA cGMP, and CE mark guidelines.
Opportunities
Risk Factors
Competitive Landscape
LifeSign competes in the crowded rapid diagnostics market against large, diversified medtech companies (e.g., Abbott, QuidelOrtho, Roche) and numerous smaller specialists. Competition is based on test accuracy, cost, distribution reach, and brand trust. Its niche is serving diverse non-hospital settings with a broad menu of tests.